3 Numbers That Don’t Lie About Banco Santander SA

Banco Santander SA (LON:BNC) still looks good, but there are some potential pitfalls for UK investors.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

SantanderAny analysis of Banco Santander SA (LSE: BNC) (NYSE: .US) usually focuses on its massive dividend yield and its attractive exposure to Latin America. I’m a big fan of both, but they don’t tell the whole story, especially for UK investors.

In this article, I’ve taken a look at three Santander numbers you may not be familiar with — including one that has the potential to put a serious dent in your investment returns.

1.  5.45%

Santander’s non-performing loan rate — typically defined as loans more than 90 days in arrears — is 5.45%, compared to 5.0% at Lloyds Banking Group, 2.6% at Barclays and 8.3% at Royal Bank of Scotland Group.

Although each bank’s business mix and definition of non-performing is slightly different, it’s clear that Santander does still have a significant burden of bad debt, especially in Spain, where the non-performing loan rate was a chunky 7.59% at the end of June.

2.  -12%

Many UK-listed companies are currently reporting falling profits, thanks to ‘currency effects’ — the strength of the pound against most other currencies.

Santander’s reporting currency is Euros, so if anything, it’s benefited from the strong pound. 

However, UK shareholders have not benefited, as the strength of the pound against the Euro has slashed returns from Santander shares over the last year:

  Euros
(Madrid listing)
Currency effect GBP
(London listing)
1yr share price gain 28% -12% 16%

It’s a similar story with the bank’s €0.60 dividend, which was worth 51.6p in August 2013, but is only worth 47.6p today — although this still equates to an incredible 8.4% yield.

3.  47.3% vs 114%

In this final section I want to break my own rules and highlight two numbers — one good, and one less good.

The good: The cost:income ratio is a key metric for banks, as it shows how much of a bank’s interest income gets eaten up by operating costs. Santander’s cost:income ratio is an impressive 47.3% — lower than any other UK-listed bank.

The bad: A second key ratio for banks is the loan:deposit ratio, which compares total loans with total deposits. Most banks target a loan:deposit ratio of less than 100%, to avoid the risk of liquidity problems; being unable to meet sudden funding requirements.

Santander’s loan:deposit ratio is 114%, which is higher than any other UK bank.

So is Santander a buy?

In my view, Santander size and geographic diversity make it a buy, despite the currency risks for UK investors (which could eventually reverse) and its relatively high levels of bad debt.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Roland Head owns shares in Barclays. The Motley Fool has no position in any of the shares mentioned.

More on Investing Articles

Concept of two young professional men looking at a screen in a technological data centre
Investing Articles

If I’d put £5,000 in Nvidia stock at the start of 2024, here’s what I’d have now

Nvidia stock was a massive winner in 2023 as the AI chipmaker’s profits surged across the year. How has it…

Read more »

Light bulb with growing tree.
Investing Articles

3 top investment trusts that ‘green’ up my Stocks and Shares ISA

I’ll be buying more of these investment trusts for my Stocks and Shares ISA given the sustainable and stable returns…

Read more »

Investing Articles

8.6% or 7.2%? Does the Legal & General or Aviva dividend look better?

The Aviva dividend tempts our writer. But so does the payout from Legal & General. Here he explains why he'd…

Read more »

a couple embrace in front of their new home
Investing Articles

Are Persimmon shares a bargain hiding in plain sight?

Persimmon shares have struggled in 2024, so far. But today's trading update suggests sentiment in the housing market's already improving.

Read more »

Market Movers

Here’s why the Unilever share price is soaring after Q1 earnings

Stephen Wright isn’t surprised to see the Unilever share price rising as the company’s Q1 results show it’s executing on…

Read more »

Investing Articles

Barclays’ share price jumps 5% on Q1 news. Will it soon be too late to buy?

The Barclays share price has been having a great time this year, as a solid Q1 gives it another boost.…

Read more »

Young black colleagues high-fiving each other at work
Investing Articles

The AstraZeneca share price lifts 5% on a top-and-bottom earnings beat

The AstraZeneca share price reached £120 today and helped push the FTSE 100 higher. Would I still buy this flying…

Read more »

Young black woman using a mobile phone in a transport facility
Market Movers

Meta stock slumps 13% after poor results. Here’s what I’ll do

Jon Smith flags up the reasons behind the fall in the Meta stock price overnight, along with his take on…

Read more »